Cross-Talk between Available Guidelines for the Management of Patients with Beta-Thalassemia Major

Publisher： Karger

E-ISSN： 1421-9662|130|2|64-73

ISSN： 0001-5792

Source： Acta Haematologica, Vol.130, Iss.2, 2013-03, pp. : 64-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunological Evaluation of Patients with Beta-Thalassemia major

By  

Acta Haematologica, Vol. 105, Iss. 1, 2001-04 ,pp. : 7-12

Karger

Access to resources Recommend Favorite

Determinants of Pulmonary Hypertension in Patients with Beta-Thalassemia Major and Normal Ventricular Function

By  

Acta Haematologica, Vol. 128, Iss. 2, 2012-07 ,pp. : 124-129

Karger

Access to resources Recommend Favorite

Increased Serum Heat Shock Protein 27 Antibody Titers and Prooxidant-Antioxidant Balance in Patients with Beta-Thalassemia Major

By  

Acta Haematologica, Vol. 129, Iss. 1, 2012-09 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Hypercoagulable State and Methylenetetra- hydrofolate Reductase (MTHFR) C677T Mutation in Patients with Beta-Thalassemia Major in Kuwait

By  

Acta Haematologica, Vol. 123, Iss. 1, 2009-11 ,pp. : 37-42

Karger

Access to resources Recommend Favorite

Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox

By  

Acta Haematologica, Vol. 123, Iss. 3, 2010-02 ,pp. : 148-152

Karger

Access to resources Recommend Favorite